MVM Life Science Partners 
MVM was founded in 1997 and manages three funds totalling $500 million.

MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare IT, healthcare services, medical devices, OTC medicines, research tools and vaccines.

Current portfolio companies are based across Europe, Israel and in the US.

The MVM team has broad experience across the life science and venture capital markets and maintains offices in London and Boston.